National Medical Care Co. announces to Invites its Shareholders to Attend the (First Meeting) Extraordinary General Assembly Meeting through the modern technology means

Element List	Explanation
Introduction	The Board of Directors of the National Medical Care Company is pleased to invite the shareholders to participate and vote in the Extraordinary General Assembly Meeting (first meeting), which is scheduled to be held at 8:00 pm on Wednesday 22/05/2024, through modern technology
City and Location of the General Assembly's Meeting	The company's headquarter in Riyadh, by means of modern technology
Hyperlink of the Meeting Location	Click Here
Date of the General Assembly's Meeting	2024-05-22 Corresponding to 1445-11-14
Time of the General Assembly’s Meeting	20:00
Methodology of Convening the General Assembly’s Meeting	Via modern technology means
Attendance Eligibility, Registration Eligibility, and Voting End	Shareholders Registered in the company’s Shareholders Registry in the Depository Centre at the End of the Trading Session Preceding the Assembly’s Meeting as per Laws and Regulations Eligibility for Registering the Attendance of the General Assembly’s Meeting Ends upon the Convenience of the General Assembly’s Meeting. Eligibility for Voting on the Business of the Meeting Agenda Ends upon the Counting Committee Concludes Counting the Votes
Quorum for Convening the General Assembly's Meeting	The extraordinary general assembly meeting will be valid if it is attended by shareholders representing at least half of the capital. If a quorum is not present at the first meeting, the second meeting will be held one hour after the end of the period specified for the first meeting. The second meeting will be valid if it is attended by shareholders representing a quarter of the capital.
General Assembly Meeting Agenda	1- Review and discuss Board of Directors Report for the fiscal year ended on 31/12/2023. 2- Voting on External Auditor Report for the fiscal year ended on 31/12/2023 after discuss. 3-Review and discuss Financial Statements for the fiscal year ended on 31/12/2023. 4- Voting on the discharge of Board of Directors members for the fiscal year ended on 31/12/2023. 5- Vote on appointing the company’s auditor from among the candidates, based on the recommendation of the Audit Committee, in order to examine, review and audit the financial statements for a period of three years from the second and third quarters and the annual of the year 2024 and the first, second and third quarters and the annual of the year 2025 and the first, second and third quarters and the annual of the year 2026. and the first quarter of the year 2027 and determining his fees. 6- Voting on the Board of Directors’ recommendation to distribute cash dividends in the amount of (89,700,000) SAR to shareholders for the financial period 31/12/2023 (at 2 riyals per share and 20% of the capital), provided that the eligibility is for shareholders who own shares at the end of trading on the day of the General Assembly meeting and those registered in the company’s shareholder register at the Securities Depository Center Company (Edaa) at the end of the second trading day following the maturity date, and the dividend distribution date will be announced later. 7-Voting on disbursement of (1,900,000) SAR as remuneration to Board members for the fiscal year ended on 31/12/2023. 8- Voting on transferring Statutory Reserve balance amounted (186,021,947) SAR as stated in the financial statements for the year ended on 31/12/2023 to the Retained Earnings account. 9-Vote on the employee stock program and to authorize the Board of Directors to determine the terms of this program, including the allocation price for each share offered to employees if it is for a consideration. 10-Voting on the company’s purchase of a number of its shares, up to a maximum of (160,000) shares, with the aim of allocating them to company's employees within the framework of the employee stock program, provided that the purchase is self-financing and authorizing the Board of Directors to complete the purchase process within a maximum period of (12) months from the date of the assembly’s decision. Extraordinary General Assembly, provided that the purchased shares are kept for a period not exceeding (10) years from the date of approval by the Extraordinary General Assembly. After the expiry of this period, the company follows the procedures and controls stipulated in the relevant laws and regulations. “after approving item 9”
Proxy Form
The shareholder right in discussing the assembly agenda topics, asking questions, and exercising the voting right	The shareholders has the right to discuss the topics on the agenda of the Assembly and ask questions and the voting on the agenda items of the AGM will be solely electronically through Tadawulaty.
Details of the electronic voting on the Assembly’s agenda	The voting on the agenda items of the AGM will be solely electronically through Tadawulaty, which will start on Saturday, 18 May 2024,1:00 am. and ends at the closure of the General Assembly Meeting. Registration and voting shall be available free of charge in Tadawulaty services for all shareholders by using the following link: https://www.tadawulaty.com.sa
Method of Communication in Case of Any Enquiries	In case of inquiries, we hope to communicate with shareholders' relations management (Tel: 0114931881) or email: (Care.ir@care.med.sa)
Attached Documents